Predictions
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
Avinger Inc.
Start price
Target price
Perf. (%)
€4.88
14.12.20
14.12.20
€20.00
301.64%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€0.72
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
9.69%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€13.00
14.12.20
14.12.20
€25.00
14.12.21
14.12.21
71.15%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€6.00
14.12.20
14.12.20
€8.00
14.12.21
14.12.21
6.67%
11.01.21
11.01.21
Could be very worthwhile Investment >20% year
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.36
13.12.20
13.12.20
-
13.12.21
13.12.21
-5.96%
10.01.21
10.01.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Nanostr.technol.
Start price
Target price
Perf. (%)
€57.50
13.12.20
13.12.20
-
13.12.21
13.12.21
-41.91%
14.12.21
14.12.21
Risky Investment
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.10
30.11.20
30.11.20
€14.00
30.11.21
30.11.21
-7.21%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.50
30.11.20
30.11.20
€15.00
30.11.21
30.11.21
31.85%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€21.00
30.11.20
30.11.20
€25.00
30.11.21
30.11.21
-15.71%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
30.11.20
30.11.20
€7.00
30.11.21
30.11.21
-
14.12.20
14.12.20
Could be very worthwhile Investment >20% year
Axonics Modulation Technologies Inc
Start price
Target price
Perf. (%)
€37.20
28.11.20
28.11.20
€42.00
28.11.21
28.11.21
31.72%
29.11.21
29.11.21
Could be worthwhile Investment >10% per year
Veeva Systems A
Start price
Target price
Perf. (%)
€230.05
28.11.20
28.11.20
-
28.11.21
28.11.21
12.50%
29.11.21
29.11.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Medium risks for its business
Teleflex Inc.
Start price
Target price
Perf. (%)
€308.00
20.11.20
20.11.20
-
20.11.21
20.11.21
8.44%
14.02.21
14.02.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.50
16.11.20
16.11.20
€13.00
16.11.21
16.11.21
-3.48%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.20
16.11.20
16.11.20
€15.00
16.11.21
16.11.21
2.27%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€18.10
16.11.20
16.11.20
€20.00
16.11.21
16.11.21
16.02%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
16.11.20
16.11.20
€7.00
16.11.21
16.11.21
-
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.97
12.11.20
12.11.20
€50.00
12.11.21
12.11.21
21.49%
13.07.21
13.07.21
Top 10 in its market
Small cyclical dependencies
Below average Management
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.41
09.11.20
09.11.20
€40.00
09.11.21
09.11.21
18.27%
02.11.21
02.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Bio-Gate AG
Start price
Target price
Perf. (%)
€5.90
04.11.20
04.11.20
-
04.11.21
04.11.21
-32.20%
05.11.21
05.11.21
Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
Humana Inc.
Start price
Target price
Perf. (%)
€364.00
03.11.20
03.11.20
-
04.11.21
04.11.21
-6.04%
14.01.21
14.01.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
Misonix Inc.
Start price
Target price
Perf. (%)
€9.55
02.11.20
02.11.20
€11.00
04.11.21
04.11.21
4.19%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year